Choroidal Effusions after Glaucoma Drainage Implant Surgery

被引:1
作者
Ying, Stephanie [1 ]
Coulon, Sara J. [2 ]
Lidder, Alcina K. [2 ]
Labowsky, Mary [3 ]
Cheng, Christopher P. [1 ]
Vinod, Kateki [1 ,3 ]
Sidoti, Paul A. [1 ,3 ]
Panarelli, Joseph F. [2 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY USA
[2] New York Univ Langone Hlth, Dept Ophthalmol, New York, NY USA
[3] New York Eye & Ear Infirm Mt Sinai, Dept Ophthalmol, New York, NY USA
来源
OPHTHALMOLOGY GLAUCOMA | 2023年 / 6卷 / 05期
关键词
Choroidal effusion; Glaucoma drainage implant; Surgical drainage; RANDOMIZED CLINICAL-TRIAL; TREATMENT OUTCOMES; BAERVELDT; TRABECULECTOMY; DETACHMENT; COMPLICATIONS; THERAPY;
D O I
10.1016/j.ogla.2023.03.002
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To report the incidence of patients who developed choroidal effusions after glaucoma drainage implant (GDI) surgery and determine risk factors for and outcomes of surgical intervention. Design: Retrospective case series. Subjects: Medical records of 605 patients who underwent GDI surgery from January 1, 2017 to June 7, 2021 at New York University Langone Health and New York Eye and Ear Infirmary of Mount Sinai were reviewed. Methods: Preoperative, intraoperative, and postoperative clinical data were obtained. Multivariate logistic regression evaluated the factors associated with the need for surgical intervention. Patient records were analyzed for effusion resolution, intraocular pressure (IOP), visual acuity (VA), and complications across treatment modalities. Main Outcome Measures: Incidence of choroidal effusion development and need for surgical intervention. Results: Choroidal effusions developed in 110 (18%) patients (110 eyes). Surgical intervention to drain the effusion or ligate the implant tube was performed in 19 (17%) patients. The average time to surgical intervention was 47.6 days. Among patients who developed postoperative effusions, risk factors for requiring surgical intervention included history of selective laser trabeculoplasty (SLT) (P = 0.004; odds ratio [OR], 14.4), prior GDI surgery (P = 0.04; OR 8.7), 350-mm(2) Baerveldt glaucoma implant placement (P = 0.05; OR, 4.8), and anterior chamber shallowing (AC; P < 0.001; OR, 25.1) in the presence of effusions. The subgroup that required multiple surgeries for effusion resolution had a significantly lower mean IOP at the most recent follow-up compared with those who received medical management only (P < 0.001). A higher percentage of patients who required surgical intervention lost VA at the most recent follow-up compared with patients whose effusions resolved with con-servative management (i.e., medical management, AC viscoelastic injection). Conclusions: Choroidal effusions after GDI surgery resolved with conservative management in most pa-tients. A history of SLT or GDI placement, implantation of a BGI-350, and the presence of a shallow chamber were risk factors for surgical intervention. Although interventions, such as surgical drainage are at times necessary, a better understanding of their impacts can help guide postoperative decisions. The risks and benefits of these procedures must be carefully considered in these high-risk eyes. (c) 2023 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology
引用
收藏
页码:530 / 540
页数:11
相关论文
共 23 条
  • [1] Long-term Efficacy of the Baerveldt 250 mm2 Compared with the Baerveldt 350 mm2 Implant
    Allan, Evan J.
    Khaimi, Mahmoud A.
    Jones, Joshua M.
    Ding, Kai
    Skuta, Gregory L.
    [J]. OPHTHALMOLOGY, 2015, 122 (03) : 486 - 493
  • [2] Three-year Treatment Outcomes in the Ahmed Baerveldt Comparison Study
    Barton, Keith
    Feuer, William J.
    Budenz, Donald L.
    Schiffman, Joyce
    Costa, Vital P.
    Godfrey, David G.
    Buys, Yvonne M.
    [J]. OPHTHALMOLOGY, 2014, 121 (08) : 1547 - +
  • [3] BELLOWS AR, 1981, OPHTHALMOLOGY, V88, P1107
  • [4] BERKE SJ, 1987, OPHTHALMOLOGY, V94, P154
  • [5] Randomized clinical trial of the 350-mm2 versus the 500-mm2 Baerveldt implant:: Longer term results -: Is bigger better?
    Britt, MT
    LaBree, LD
    Lloyd, MA
    Minckler, DS
    Heuer, DK
    Baerveldt, G
    Varma, R
    [J]. OPHTHALMOLOGY, 1999, 106 (12) : 2312 - 2318
  • [6] Five-Year Treatment Outcomes in the Ahmed Baerveldt Comparison Study
    Budenz, Donald L.
    Barton, Keith
    Gedde, Steven J.
    Feuer, William J.
    Schiffman, Joyce
    Costa, Vital P.
    Godfrey, David G.
    Buys, Yvonne M.
    [J]. OPHTHALMOLOGY, 2015, 122 (02) : 308 - 316
  • [7] The Ahmed Versus Baerveldt Study Five-Year Treatment Outcomes
    Christakis, Panos G.
    Kalenak, Jeffrey W.
    Tsai, James C.
    Zurakowski, David
    Kammer, Jeffrey A.
    Harasymowycz, Paul J.
    Mura, Juan J.
    Cantor, Louis B.
    Ahmed, Iqbal I. K.
    [J]. OPHTHALMOLOGY, 2016, 123 (10) : 2093 - 2102
  • [8] de Barros DSM, 2009, J GLAUCOMA, V18, P13, DOI 10.1097/IJG.0b013e31816f7647
  • [9] Postoperative Complications in the Tube Versus Trabeculectomy (TVT) Study During Five Years of Follow-up
    Gedde, Steven J.
    Herndon, Leon W.
    Brandt, James D.
    Budenz, Donald L.
    Feuer, William J.
    Schiffman, Joyce C.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (05) : 804 - 814
  • [10] Risk factors for choroidal detachment after trabeculectomy with mitomycin C
    Haga, Akira
    Inatani, Masaru
    Shobayashi, Kohei
    Kojima, Sachi
    Inoue, Toshihiro
    Tanihara, Hidenobu
    [J]. CLINICAL OPHTHALMOLOGY, 2013, 7 : 1417 - 1421